[
    [
        {
            "time": "2019-11-25",
            "original_text": "Novartis to buy drug maker The Medicines Co. for $9.7 billion",
            "features": {
                "keywords": [
                    "Novartis",
                    "buy",
                    "The Medicines Co.",
                    "$9.7 billion"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-11-25",
            "original_text": "Novartis Announces $9.7 Billion Takeover Of The Medicines Company",
            "features": {
                "keywords": [
                    "Novartis",
                    "Announces",
                    "$9.7 Billion",
                    "Takeover",
                    "The Medicines Company"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-11-25",
            "original_text": "Novartis to buy U.S. biotech The Medicines Co. for $9.7 billion",
            "features": {
                "keywords": [
                    "Novartis",
                    "buy",
                    "U.S.",
                    "biotech",
                    "The Medicines Co.",
                    "$9.7 billion"
                ],
                "sentiment_score": 0.88,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-11-25",
            "original_text": "UPDATE 3-Novartis takes on Sanofi, Amgen with $9.7 bln takeover of heart drug maker",
            "features": {
                "keywords": [
                    "Novartis",
                    "Sanofi",
                    "Amgen",
                    "$9.7 bln",
                    "takeover",
                    "heart drug maker"
                ],
                "sentiment_score": 0.82,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-11-25",
            "original_text": "Novartis to Swallow Up The Medicines Company for $9.7 Billion",
            "features": {
                "keywords": [
                    "Novartis",
                    "Swallow Up",
                    "The Medicines Company",
                    "$9.7 Billion"
                ],
                "sentiment_score": 0.87,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-11-25",
            "original_text": "Novartis Nears Deal to Buy Medicines Co. for $85/Share: WSJ",
            "features": {
                "keywords": [
                    "Novartis",
                    "Nears Deal",
                    "Buy",
                    "Medicines Co.",
                    "$85/Share"
                ],
                "sentiment_score": 0.84,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-11-25",
            "original_text": "Novartis agrees $9.7bn deal for US cholesterol drugmaker",
            "features": {
                "keywords": [
                    "Novartis",
                    "agrees",
                    "$9.7bn",
                    "deal",
                    "US",
                    "cholesterol",
                    "drugmaker"
                ],
                "sentiment_score": 0.86,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2019-11-25",
            "original_text": "[video]Novartis Reportedly Close to Buying Medicines Co.",
            "features": {
                "keywords": [
                    "Novartis",
                    "Reportedly Close",
                    "Buying",
                    "Medicines Co."
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]